Display options
Cite
Koito A, Ikeda T. Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases. Front Microbiol. 2013;4:28doi: 10.3389/fmicb.2013.00028.
Koito, A., & Ikeda, T. (2013). Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases. Frontiers in microbiology, 428. https://doi.org/10.3389/fmicb.2013.00028
Koito, Atsushi, and Ikeda, Terumasa. "Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases." Frontiers in microbiology vol. 4 (2013): 28. doi: https://doi.org/10.3389/fmicb.2013.00028
Koito A, Ikeda T. Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases. Front Microbiol. 2013 Feb 20;4:28. doi: 10.3389/fmicb.2013.00028. eCollection 2013. PMID: 23431045; PMCID: PMC3576619.
Copy Download .nbib Format: NLM
Share it on

Front Microbiol. 2013 Feb 20;4:28. doi: 10.3389/fmicb.2013.00028. eCollection 2013.

Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases.

Frontiers in microbiology

Atsushi Koito, Terumasa Ikeda

Affiliations

  1. Department of Retrovirology and Self-Defense, Faculty of Life Sciences, Kumamoto University Kumamoto, Japan.

PMID: 23431045 PMCID: PMC3576619 DOI: 10.3389/fmicb.2013.00028

Abstract

Over 40% of the human genome is recognizable as having been derived from ancient retroelements, transported by an intracellular copy-and-paste process involving an RNA intermediate, with an additional few percent classified as DNA transposable elements. Endogenous retroviruses are long terminal repeat (LTR)-type retroelements that account for ~8% of human genomic DNA. Non-LTR members are present at extremely high copy numbers, with ~17% of the human genome consisting of long interspersed nuclear elements (LINEs). These LINEs modify vertebrate genomes not only through insertions, but also by the indirect replication of non-autonomous retrotransposons, such as short interspersed nuclear elements. As expected, vertebrate intrinsic immunity has evolved to support a balance between retroelement insertions that confer beneficial genetic diversity and those that cause deleterious gene disruptions. The mammalian cytidine deaminases encoded by the APOBEC3 genes can restrict a broad number of exogenous pathogens, such as exogenous retroviruses, and the mobility of endogenous retroelements. Furthermore, APOBEC1 from a variety of mammalian species, which mediates the cytidine (C) to uridine (U) deamination of apolipoprotein B (apoB) mRNA, a protein involved in lipid transport, also plays a role in controlling mobile elements. These mammalian apoB mRNA-editing, catalytic polypeptide (APOBEC) cytidine deaminases, which can bind to single-stranded DNA (ssDNA) as well as RNA, are able to insert mutations into ssDNA and/or RNA as a result of their ability to deaminate C to U. While these APOBEC cytidine deaminases with DNA mutagenic activity can be deleterious to cells, their biological modifications, such as protein-protein interactions and subcellular localization, in addition to their ability to bind to RNA, appear to have conferred a role for APOBECs as a cellular defense system against retroviruses and retroelements. In support of this notion, the expansion of the single APOBEC3 gene in mice to the seven APOBEC3 genes found in primates apparently correlates with the significant enhancement of the restriction of endogenous retroelements seen in primates, including humans. This review discusses the current understanding of the mechanism of action of APOBEC cytidine deaminases and attempts to summarize their roles in controlling retrotransposons.

Keywords: AID; APOBEC1; APOBEC3; HIV-1; LINE-1; endogenous retrovirus; retroelements; retrovirus

References

  1. Curr Opin Genet Dev. 2010 Apr;20(2):149-55 - PubMed
  2. J Biol Chem. 2007 Nov 16;282(46):33632-33640 - PubMed
  3. Science. 2004 Jul 30;305(5684):645 - PubMed
  4. Trends Biochem Sci. 2007 Mar;32(3):118-28 - PubMed
  5. Nat Struct Mol Biol. 2004 May;11(5):435-42 - PubMed
  6. Nature. 2008 Oct 2;455(7213):661-4 - PubMed
  7. Mol Cell Biol. 1996 Aug;16(8):4495-503 - PubMed
  8. RNA. 2008 Jun;14(6):1228-36 - PubMed
  9. Nature. 2002 Aug 8;418(6898):646-50 - PubMed
  10. Annu Rev Genet. 2008;42:709-32 - PubMed
  11. Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):19945-8 - PubMed
  12. Gene. 2007 Apr 1;390(1-2):199-205 - PubMed
  13. Genes Dev. 2009 Jun 1;23(11):1303-12 - PubMed
  14. Hum Mol Genet. 2004 May 15;13(10):1041-8 - PubMed
  15. Ann N Y Acad Sci. 2009 Oct;1178:268-75 - PubMed
  16. Cell. 1996 Nov 29;87(5):917-27 - PubMed
  17. Gene. 2009 Dec 15;448(2):115-23 - PubMed
  18. J Virol. 2011 Sep;85(17):9139-46 - PubMed
  19. J Virol. 2008 Sep;82(17):8762-70 - PubMed
  20. Nat Struct Mol Biol. 2006 Sep;13(9):763-71 - PubMed
  21. Nucleic Acids Res. 2006 Mar 14;34(5):1522-31 - PubMed
  22. Curr Biol. 2006 Aug 8;16(15):1565-70 - PubMed
  23. Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14572-9 - PubMed
  24. Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8780-5 - PubMed
  25. J Virol. 2007 Sep;81(17):9577-83 - PubMed
  26. J Virol. 2008 Jul;82(13):6566-75 - PubMed
  27. Nat Genet. 2004 May;36(5):534-9 - PubMed
  28. Curr Opin Genet Dev. 2012 Jun;22(3):191-203 - PubMed
  29. Retrovirology. 2009 Mar 09;6:26 - PubMed
  30. Retrovirology. 2008 Aug 14;5:75 - PubMed
  31. Cell. 1996 Nov 29;87(5):905-16 - PubMed
  32. RNA. 2006 Jan;12(1):94-101 - PubMed
  33. Int J Cancer. 2010 Jan 15;126(2):306-14 - PubMed
  34. Nat Rev Genet. 2009 Oct;10(10):691-703 - PubMed
  35. Immunol Invest. 1999 Jul;28(4):277-89 - PubMed
  36. J Virol. 2008 Feb;82(3):1305-13 - PubMed
  37. Mol Cell Biol. 1998 Jan;18(1):58-68 - PubMed
  38. FASEB J. 2009 Jan;23(1):279-87 - PubMed
  39. Nature. 2011 Oct 30;479(7374):534-7 - PubMed
  40. Retrovirology. 2012 Jun 22;9:53 - PubMed
  41. Mob Genet Elements. 2011 Sep;1(3):197-202 - PubMed
  42. Virology. 2009 Mar 15;385(2):455-63 - PubMed
  43. Nature. 2005 Sep 1;437(7055):69-87 - PubMed
  44. J Virol. 2008 Mar;82(6):2652-60 - PubMed
  45. Nucleic Acids Res. 2009 Apr;37(6):1854-67 - PubMed
  46. J Virol. 2009 Sep;83(18):9474-85 - PubMed
  47. Development. 2008 Jan;135(1):3-9 - PubMed
  48. Nucleic Acids Res. 2008 Dec;36(21):6859-71 - PubMed
  49. Mol Cell. 2009 Jun 26;34(6):696-709 - PubMed
  50. Science. 1990 Nov 23;250(4984):1127-9 - PubMed
  51. Hum Mol Genet. 2004 Aug 15;13(16):1785-91 - PubMed
  52. Genetics. 2009 Jan;181(1):301-11 - PubMed
  53. Cell Host Microbe. 2008 Apr 17;3(4):206-12 - PubMed
  54. J Virol. 2006 Apr;80(8):3853-62 - PubMed
  55. Annu Rev Genet. 2008;42:587-617 - PubMed
  56. Science. 2006 Jul 28;313(5786):523-6 - PubMed
  57. Cytogenet Genome Res. 2005;110(1-4):448-56 - PubMed
  58. Cell. 1991 Jan 11;64(1):159-70 - PubMed
  59. Nat Genet. 2003 Sep;35(1):41-8 - PubMed
  60. J Biol Chem. 2006 Sep 29;281(39):29105-19 - PubMed
  61. Nat Struct Mol Biol. 2006 Jul;13(7):655-60 - PubMed
  62. Science. 2004 Mar 12;303(5664):1626-32 - PubMed
  63. Science. 2000 Jun 9;288(5472):1789-96 - PubMed
  64. Nature. 2004 May 20;429(6989):268-74 - PubMed
  65. Wiley Interdiscip Rev RNA. 2012 Jul-Aug;3(4):529-41 - PubMed
  66. J Mol Biol. 2005 May 6;348(3):549-61 - PubMed
  67. Annu Rev Immunol. 2008;26:317-53 - PubMed
  68. Mol Biol Evol. 1999 Jun;16(6):793-805 - PubMed
  69. BMC Mol Biol. 2008 Nov 18;9:104 - PubMed
  70. Dev Biol (Basel). 2001;106:439-41; discussion 465-75 - PubMed
  71. J Virol. 2005 Jul;79(13):8201-7 - PubMed
  72. Trends Genet. 2004 Jan;20(1):9-14 - PubMed
  73. PLoS Pathog. 2007 Jan;3(1):e10 - PubMed
  74. PLoS Biol. 2004 Sep;2(9):E275 - PubMed
  75. Cell. 2012 Jan 20;148(1-2):335-48 - PubMed
  76. J Virol. 2003 Nov;77(21):11448-58 - PubMed
  77. Nucleic Acids Res. 2011 Jul;39(13):5538-54 - PubMed
  78. PLoS Genet. 2007 Oct;3(10):2014-22 - PubMed
  79. J Virol. 2007 Mar;81(5):2165-78 - PubMed
  80. J Virol. 2011 Nov;85(21):11220-34 - PubMed
  81. PLoS Pathog. 2007 Feb;3(2):e15 - PubMed
  82. Nat Rev Genet. 2002 May;3(5):370-9 - PubMed
  83. Nucleic Acids Res. 2007;35(9):2955-64 - PubMed
  84. Nature. 2004 Apr 1;428(6982):493-521 - PubMed
  85. Nucleic Acids Res. 2006 Jan 10;34(1):89-95 - PubMed
  86. Nature. 2001 Feb 15;409(6822):860-921 - PubMed
  87. J Biol Chem. 2003 Mar 7;278(10):8112-7 - PubMed
  88. J Virol. 2012 Oct;86(19):10517-23 - PubMed
  89. J Neuroimmune Pharmacol. 2010 Sep;5(3):326-35 - PubMed
  90. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7831-5 - PubMed
  91. J Virol. 2011 Jul;85(13):6244-51 - PubMed
  92. Genomics. 2002 Mar;79(3):285-96 - PubMed
  93. Science. 1991 Dec 20;254(5039):1808-10 - PubMed
  94. Virology. 2008 Aug 15;378(1):69-78 - PubMed
  95. Retrovirology. 2011 Jan 06;8:2 - PubMed
  96. J Virol. 2008 Nov;82(22):10998-1008 - PubMed
  97. Semin Cancer Biol. 2010 Aug;20(4):211-21 - PubMed
  98. J Virol. 2000 Apr;74(8):3715-30 - PubMed
  99. J Virol. 2008 Sep;82(17):8743-61 - PubMed
  100. Nature. 2007 Feb 22;445(7130):927-30 - PubMed
  101. J Mol Biol. 2009 Jan 9;385(1):65-78 - PubMed
  102. Genome Res. 2004 Nov;14(11):2261-7 - PubMed
  103. Mol Cell Biol. 2005 Aug;25(16):7270-7 - PubMed
  104. PLoS Pathog. 2006 May;2(5):e41 - PubMed
  105. J Lipid Res. 1993 Aug;34(8):1367-83 - PubMed
  106. Nature. 2002 Dec 5;420(6915):520-62 - PubMed
  107. Nature. 2005 Jan 27;433(7024):430-3 - PubMed

Publication Types